As of 2025-05-22, the EV/EBITDA ratio of Noxopharm Ltd (NOX.AX) is -3.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NOX.AX's latest enterprise value is 18.25 mil AUD. NOX.AX's TTM EBITDA according to its financial statements is -4.60 mil AUD. Dividing these 2 quantities gives us the above NOX.AX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 13.7x | 10.6x |
| Forward P/E multiples | 6.2x - 12.4x | 9.3x |
| Fair Price | (0.11) - (0.19) | (0.15) |
| Upside | -272.8% - -390.5% | -331.7% |
| Date | EV/EBITDA |
| 2025-05-13 | -4.35 |
| 2025-05-12 | -4.35 |
| 2025-05-09 | -4.73 |
| 2025-05-08 | -4.61 |
| 2025-05-07 | -4.67 |
| 2025-05-06 | -4.73 |
| 2025-05-05 | -4.54 |
| 2025-05-02 | -4.54 |
| 2025-05-01 | -4.35 |
| 2025-04-30 | -4.86 |
| 2025-04-28 | -4.73 |
| 2025-04-24 | -4.67 |
| 2025-04-23 | -4.67 |
| 2025-04-22 | -5.18 |
| 2025-04-17 | -5.12 |
| 2025-04-15 | -4.35 |
| 2025-04-10 | -4.16 |
| 2025-04-09 | -4.10 |
| 2025-04-08 | -4.16 |
| 2025-04-07 | -4.16 |
| 2025-04-04 | -4.03 |
| 2025-04-03 | -4.67 |
| 2025-04-02 | -4.86 |
| 2025-04-01 | -4.73 |
| 2025-03-31 | -4.99 |
| 2025-03-28 | -5.18 |
| 2025-03-27 | -5.18 |
| 2025-03-26 | -5.31 |
| 2025-03-25 | -5.31 |
| 2025-03-24 | -5.31 |
| 2025-03-21 | -5.18 |
| 2025-03-20 | -5.12 |
| 2025-03-19 | -4.48 |
| 2025-03-18 | -4.42 |
| 2025-03-17 | -4.48 |
| 2025-03-14 | -4.61 |
| 2025-03-13 | -4.99 |
| 2025-03-12 | -4.61 |
| 2025-03-11 | -4.35 |
| 2025-03-10 | -4.42 |
| 2025-03-07 | -4.42 |
| 2025-03-05 | -5.05 |
| 2025-03-04 | -4.92 |
| 2025-03-03 | -4.99 |
| 2025-02-28 | -5.24 |
| 2025-02-27 | -5.50 |
| 2025-02-26 | -5.12 |
| 2025-02-25 | -5.50 |
| 2025-02-24 | -4.99 |
| 2025-02-21 | -4.92 |